Evidence map›Paper›PMID 42180329›Full record

ArticlemedRxiv : the preprint server for health sciences2026

CBCRisk-Mastectomy: A Risk Prediction Tool to Aid Contralateral Prophylactic Mastectomy Decision Making.

Ibrahim Hossain Sajal, Ruth M Pfeiffer, Ismail Jatoi, Mitchell H Gail, Reena S Cecchini, Pankaj K Choudhary, Swati Biswas

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Ibrahim Hossain SajalDepartment of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, USA.
Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Ismail JatoiDivision of Surgical Oncology and Endocrine Surgery, University of Texas Health Science Center, San Antonio, TX, USA.
Mitchell H GailDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Reena S CecchiniUniversity of Pittsburgh, Pittsburgh, PA, USA.
Pankaj K ChoudharyDepartment of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, USA.
Swati BiswasDepartment of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, USA.

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
A Model for Individualized Risk Prediction of Contralateral Breast CancerR21CA186086 · NCI · UNIVERSITY OF TEXAS DALLAS · PI BISWAS, SWATI, CHOUDHARY, PANKAJ · 2014 to 2015
$412k
NCI NIH HHS P01 CA154292NCI NIH HHS R21 CA186086
6 · The paper itself

Abstract

Purpose: Unilateral breast cancer (BC) patients scheduled for mastectomy often choose to undergo contralateral prophylactic mastectomy (CPM), despite substantial declines in contralateral breast cancer (CBC) risk in recent decades. Models predicting absolute risk of future CBC can aid informed decision-making about CPM. CBCRisk is an existing CBC absolute risk prediction model trained on unilateral BC patients regardless of whether they had mastectomy. Here we developed CBCRisk-Mastectomy, tailored specifically to BC patients scheduled for mastectomy and considering CPM. Patients and Methods: We used data on BC patients who underwent mastectomy to treat their first BC from two nationally representative sources: Breast Cancer Surveillance Consortium (BCSC) and Surveillance, Epidemiology, and End Results (SEER) cancer registry. We imputed missing data in the BCSC sample and used conditional logistic regression models, trained on 2,660 BC patients (665 CBC cases) from BCSC, to identify predictors and estimate relative risks (RRs). These were combined with attributable risks and CBC incidence rates estimated from SEER to obtain absolute risk. Cross-validation was used to internally validate CBCRisk-Mastectomy and compare with CBCRisk. Results: CBCRisk-Mastectomy has nine predictors: first BC type, lobular carcinoma in situ status, estrogen receptor status, tumor stage, breast density, age at BC diagnosis, family history of BC, age at first birth, and body mass index. The areas under the curve and their 95% confidence intervals for 5-year predictions for CBCRisk-Mastectomy and CBCRisk were 0.62 (0.59, 0.65) and 0.58 (0.55, 0.61), respectively. Conclusions: CBCRisk-Mastectomy may aid clinicians in counseling BC patients scheduled for mastectomy, enabling improved decision-making regarding CPM.

Identifiers

PMID42180329
PMCPMC13193149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.